Gaoxiang Wang
Impact in
-
- CAR-T cell therapy research
Papers in
- Oncology 25
- CAR-T cell therapy research 15
- Co-authors
- Jianfeng Zhou (22 shared papers)Yang Cao (13 shared papers)Jiaqi Tan (6 shared papers)Yicheng Zhang (9 shared papers)Pan Zhou (3 shared papers)Yingquan Ye (7 shared papers)Liting Chen (10 shared papers)Liang Huang (10 shared papers)
- Journals
- Blood (7 papers)Frontiers in Oncology (4 papers)Biochemical and Biophysical Research Communications (3 papers)Infection and Drug Resistance (2 papers)Heliyon (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Gaoxiang Wang
57 papers receiving 478 citations
Peers
Comparison fields: 5 of 86
- Oncology 144
- Structural Biology 7
- Biophysics 28
- Hematology 46
- Immunology 63
Countries citing papers authored by Gaoxiang Wang
This map shows the geographic impact of Gaoxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaoxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaoxiang Wang more than expected).
Fields of papers citing papers by Gaoxiang Wang
This network shows the impact of papers produced by Gaoxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaoxiang Wang. The network helps show where Gaoxiang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Gaoxiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 35 | |
| 2 | 2019 | 34 | |
| 3 | 2019 | 30 | |
| 4 | 2021 | 25 | |
| 5 | 2020 | 25 | |
| 6 | 2018 | 20 | |
| 7 | 2022 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 16 | |
| 11 | 2023 | 15 | |
| 12 | 2022 | 14 | |
| 13 | 2023 | 13 | |
| 14 | 2020 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2023 | 12 | |
| 17 | 2022 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2024 | 10 |
About Gaoxiang Wang
Gaoxiang Wang is a scholar working on Oncology, Molecular Biology, Hematology, Cancer Research and Immunology, having authored 64 papers that have together received 483 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Cancer Genomics and Diagnostics (4 papers), Esophageal Cancer Research and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Lymphoblastic Leukemia research (3 papers), COVID-19 Clinical Research Studies (3 papers), Immune Cell Function and Interaction (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Oncology (144 citations), Structural Biology (7 citations), Biophysics (28 citations), Hematology (46 citations) and Immunology (63 citations). Gaoxiang Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jianfeng Zhou, Yang Cao, Jiaqi Tan, Yicheng Zhang, Pan Zhou, Yingquan Ye, Liting Chen, Liang Huang, Xing Chen and Cheng Sun. Their work appears in journals such as Blood, Frontiers in Oncology, Biochemical and Biophysical Research Communications, Infection and Drug Resistance and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.